![19-7-8-ThermoFisher-LOGO-300x121.jpg 19-7-8-ThermoFisher-LOGO-300x121.jpg](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/blt746ca758c0a4d7ff/658c043c64965d040a51ee36/19-7-8-ThermoFisher-LOGO-300x121.jpg?width=700&auto=webp&quality=80&disable=upscale)
![19-7-8-Gibco-F1-300x125.png 19-7-8-Gibco-F1-300x125.png](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/blt6dcb563ba3b40147/658c043dfa299e040ae48aab/19-7-8-Gibco-F1-300x125.png?width=700&auto=webp&quality=80&disable=upscale)
Figure 1: Viable cell volume (VCV) and viability data for HIP CHO in the HyPerforma 3-L Glass Bioreactor and 50-L DynaDrive Single-Use Bioreactor cell runs
At least one report estimates that by 2025, 35% of biologics will be manufactured using enhanced processes, particularly perfusion-based bioprocessing. Results of two innovations that support this need for enhanced processes are examined below.
The Thermo Scientific HyPerforma DynaDrive Single-Use Bioreactor (SUB), the latest advancement in SUB technology, offers better performance than other bioreactors and scalability up to 5,000 L. Gibco High-Intensity Perfusion CHO Medium is formulated to provide exceptional performance and ease of use, with capability of sustaining >1 g/L/day continuous productivity, >100 x 106/mL cell density, and 95% viability at one vessel volume per day (VVD).
Fill out the form below to read the complete technology review and learn more about HyPerforma DynaDrive and Gibco High-Intensity Perfusion CHO medium now.